(Q35645427)

English

TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?

scientific article published on February 2004

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

title

TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent? (English)

1 reference

stated in

Europe PubMed Central

9 August 2017

Andrew J Carter

1

1 reference

stated in

Europe PubMed Central

9 August 2017

1 February 2004

1 reference

stated in

Europe PubMed Central

9 August 2017

Catheterization and Cardiovascular Interventions

1 reference

stated in

Europe PubMed Central

9 August 2017

61

1 reference

stated in

Europe PubMed Central

9 August 2017

233-236

1 reference

stated in

Europe PubMed Central

9 August 2017

2

1 reference

stated in

Europe PubMed Central

9 August 2017

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCCD.10764

retrieved

21 January 2018

Acceleration of restenosis by diabetes: pathogenetic implications

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FCCD.10764

retrieved

21 January 2018

Identifiers

DOI

10.1002/CCD.10764

1 reference

stated in

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

PubMed ID

14755819

retrieved

9 August 2017

(Q35645427)

TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)